CHLORHEXIDINE GLUCONATE

Post-LOE

chlorhexidine gluconate 0.12% oral rinse

Molecular Devices

ANDADENTALSOLUTION

Approved

Mar 2004

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

CHLORHEXIDINE GLUCONATE (chlorhexidine gluconate 0.12% oral rinse) by Molecular Devices is clinical pharmacology: chlorhexidine gluconate oral rinse provides antimicrobial activity during oral rinsing. First approved in 2004.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY: Chlorhexidine gluconate oral rinse provides antimicrobial activity during oral rinsing. The clinical significance of chlorhexidine gluconate oral rinse's antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general reduction of counts of…

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Worked on CHLORHEXIDINE GLUCONATE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.